https://www.selleckchem.com/pr....oducts/1-4-diaminobu
Busulfan-based conditioning correlated with improved survival due to less NRM, despite its higher relapse rate when compared with melphalan-based regimens. Excess mortality was higher in transplanted patients than in the non-HCT cohort in the first year of follow-up (ratio 1.93, 95% CI 1.13-2.8, whereas the opposite occurred between the fourth and eighth follow-up years (ratio 0.31, 95% CI 0.18-0.53). Comparing the excess mortality of the two treatments, male patients seemed to benefit more than females from
Like
Comment
Share
